Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2018 2
2019 2
2020 10
2021 7
2022 5
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability.
Benvenuti L, D'Antongiovanni V, Pellegrini C, Fornai M, Bernardini N, Ippolito C, Segnani C, Di Salvo C, Colucci R, Martelli A, Flori L, Calderone V, Carta G, Ghelardi E, Calvigioni M, Panattoni A, Coppolecchia R, Arini A, Antonioli L. Benvenuti L, et al. Among authors: d antongiovanni v. Mol Nutr Food Res. 2023 Jul;67(13):e2200442. doi: 10.1002/mnfr.202200442. Epub 2023 May 16. Mol Nutr Food Res. 2023. PMID: 37099449
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice.
Panattoni A, Calvigioni M, Benvenuti L, D'Antongiovanni V, Pellegrini C, Di Salvo C, Mazzantini D, Celandroni F, Fornai M, Antonioli L, Ghelardi E. Panattoni A, et al. Among authors: d antongiovanni v. Front Microbiol. 2022 Dec 16;13:1054097. doi: 10.3389/fmicb.2022.1054097. eCollection 2022. Front Microbiol. 2022. PMID: 36590404 Free PMC article.
The intestinal barrier in disorders of the central nervous system.
Pellegrini C, Fornai M, D'Antongiovanni V, Antonioli L, Bernardini N, Derkinderen P. Pellegrini C, et al. Among authors: d antongiovanni v. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):66-80. doi: 10.1016/S2468-1253(22)00241-2. Epub 2022 Nov 2. Lancet Gastroenterol Hepatol. 2023. PMID: 36334596 Review.
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease.
Bellini G, Benvenuti L, Ippolito C, Frosini D, Segnani C, Rettura F, Pancetti A, Bertani L, D'Antongiovanni V, Palermo G, Del Prete E, Antonioli L, Nardini V, Morganti R, Pellegrini C, Bernardini N, Ceravolo R, Fornai M, Bellini M. Bellini G, et al. Among authors: d antongiovanni v. Eur J Neurol. 2023 Nov;30(11):3440-3450. doi: 10.1111/ene.15607. Epub 2022 Nov 6. Eur J Neurol. 2023. PMID: 36263629
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab.
Bertani L, Barberio B, Fornili M, Antonioli L, Zanzi F, Casadei C, Benvenuti L, Facchin S, D'Antongiovanni V, Lorenzon G, Ceccarelli L, Baglietto L, de Bortoli N, Bellini M, Costa F, Savarino EV, Fornai M. Bertani L, et al. Among authors: d antongiovanni v. Dig Liver Dis. 2022 Oct;54(10):1367-1373. doi: 10.1016/j.dld.2022.03.008. Epub 2022 Apr 4. Dig Liver Dis. 2022. PMID: 35393259
34 results